Physician profile
Jay Stuart Epstein
NPI 1760437933
$807.89
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $54.52 · 2021: $267 · 2022: $140.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $141.19 | 2019-2021 | |
| Kaleo, INC. | $118.81 | 2021-2022 | |
| Sanofi Pasteur INC. | $115.02 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $69.15 | 2019-2022 | |
| Rhodes Pharmaceuticals L.P. | $62.39 | 2019 | |
| Tris Pharma INC | $61.11 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.18 | 2021-2022 | |
| Neos Therapeutics, Lp | $49.09 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $41.19 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $32.74 | 2019 | |
| Shire North American Group INC | $28.64 | 2019 | |
| Corium, LLC | $15.24 | 2021 | |
| Cranial Technologies, INC | $15.14 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.